News tagged with celebrex
Celecoxib
Celecoxib INN ( /sɛlɨˈkɒksɪb/) is a sulfa non-steroidal anti-inflammatory drug (NSAID) and selective COX-2 inhibitor used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed by Pfizer. It is known under the brand name Celebrex or Celebra for arthritis and Onsenal for polyps. Celecoxib is available by prescription in capsule form.
For more information about Celecoxib, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Separating a cancer prevention drug from heart disease risk
Several clinical studies have shown that taking the anti-inflammatory drug celecoxib can reduce the risk of developing polyps that lead to colon cancers, at the cost of increasing the risk of heart disease. But what if this ...
Sep 13, 2011 |
not rated yet |
0
|
Common anti-inflammatory coaxes liver cancer cells to commit suicide
The anti-inflammatory drug celecoxib, known by the brand name Celebrex, triggers liver cancer cell death by reacting with a protein in a way that makes those cells commit suicide, according to a new study.
May 16, 2011 |
4.3 / 5 (6) |
0
|
Mass. doctor accused of faking pain pill data
(AP) -- A Massachusetts anesthesiologist has been accused of faking data for a dozen years in 21 published studies that suggested after-surgery benefits from painkillers including Vioxx and Celebrex.
Medicine & Health / Medications
Mar 11, 2009 |
not rated yet |
0
Search results for celebrex
Inflammatory mediator promotes colorectal cancer by stifling protective genes
Chronic inflammation combines with DNA methylation, a process that shuts down cancer-fighting genes, to promote development of colorectal cancer, scientists at The University of Texas MD Anderson Cancer Center report today ...
Jan 22, 2012 |
5 / 5 (1) |
0
|
Study of cox-2 inhibitors could lead to new class of stroke drugs
A study, in mice, by investigators at the Stanford University School of Medicine points toward potential new therapies for stroke, the nation's third-leading cause of death and foremost single cause of severe neurological ...
Oct 03, 2011 |
not rated yet |
0
|
Patients should know if their doctors get paid by drug firms
Your doctor gives you an expensive new drug to control your cholesterol, or recommends a certain brand of artificial hip, or says you need a stent to open a clogged artery.
Sep 09, 2011 |
not rated yet |
0
Red flags on pain reliever safety
For many people, pain relievers are wonder drugs, allowing them to carry on with their lives despite disabling arthritis, for instance, or recurrent headaches. But all pain relievers, whether sold over-the counter (OTC) or ...
Medicine & Health / Medications
Jul 19, 2011 |
3 / 5 (2) |
1
New hypothesis explains why drugs increase risk of heart attacks and strokes
New research shows that medications which have raised safety concerns over heart attack and stroke risks may not have gotten approval from the Food and Drug Administration (FDA) if the cardiovascular effects of fluid retention ...
Medicine & Health / Medications
Feb 23, 2011 |
5 / 5 (1) |
0
Pfizer will buy King Pharmaceuticals for $3.6B
(AP) -- Pfizer Inc. said Tuesday it will buy a company specializing in pain drugs in a $3.6 billion deal meant to shore up the portfolio of the world's largest drug company.
Oct 12, 2010 |
not rated yet |
0
When is a drug too risky to stay on the market?
(AP) -- The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. So, when is a drug too risky to ...
Medicine & Health / Medications
Jun 30, 2010 |
not rated yet |
0
Chemists find an easier way to synthesize new drug candidates
(PhysOrg.com) -- Some drugs may be more effective the longer they last inside the body. To prevent such drugs from being broken down too rapidly, pharmaceutical manufacturers often attach a fluorine-containing ...
Jun 24, 2010 |
5 / 5 (1) |
0
|
Can Celebrex prevent cancer-causing colon polyps?
Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable ...
May 13, 2010 |
not rated yet |
0
Celebrex inhibited the burden of skin cancer in high-risk patients
People with the heritable disorder of the skin called Gorlin syndrome who are genetically predisposed to develop basal cell carcinoma of the skin may have a new chemoprevention therapy on the horizon.
Jan 05, 2010 |
not rated yet |
0
List of search results for celebrex
